It is a remarkable development in the contentious debate over nicotine vaping. A group of influential tobacco control experts authored a paper, published in The American Journal of Public Health, calling on the broader health community, policymakers, and the media to re-evaluate and reform their positions on vaping in favor of vaping as a tool for harm reduction
Joining us today on RegWatch is Dr. Robin J Mermelstein, Distinguished Prof. of Psychology and IHRP Director at the University of Illinois-Chicago, and Chair of FDA’s Tobacco Products Scientific Advisory Committee. Dr. Mermelstein is one of 15 past presidents of the prestigious Society for Research on Nicotine and Tobacco that coauthored the paper.
Why does this renowned group of anti-tobacco scientists advocate for greater adult access to nicotine vaping products? Find out.
Only on RegWatch by RegulatorWatch.com
Released: Sept 2, 2021
Produced by Brent Stafford
This episode is supported by DEMAND VAPE
Want More Investigative Content?
Policy makers need to see this video and read the report. The people at the FDA who are deciding what to do with the PMTA’s should be required to see this video and read this report.
I think the FDA is denying products on personal bias rather than by following science and true facts.
We’re trying to play by the rules w/ elected and appointed criminals who run the system. I believe in science, I’m also a pragmatist. Up against essentially criminal enterprise we’re going to have to break some eggs; realize we’re going to have to get dirty.